Inovio Pharmaceuticals
INO
#9180
Rank
HK$0.87 B
Marketcap
HK$12.61
Share price
3.87%
Change (1 day)
-6.29%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.56. In 2024 the company made an earnings per share (EPS) of -HK$30.94 an increase over its 2023 EPS that were of -HK$47.70.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.45%
2024-HK$30.94-35.14%
2023-HK$47.70-56.62%
2022-HK$109.97-19.54%
2021-HK$136.6835.9%
2020-HK$100.57-11.57%
2019-HK$113.7315.24%
2018-HK$98.69-2.78%
2017-HK$101.516.93%
2016-HK$94.93134.88%
2015-HK$40.42-29.51%
2014-HK$57.34-57.34%
2013-HK$134.41146.55%
2012-HK$54.5220.83%
2011-HK$45.12-29.41%
2010-HK$63.92-48.48%
2009-HK$124.0710%
2008-HK$112.7911.11%
2007-HK$101.51-41.3%
2006-HK$172.95-66.91%
2005-HK$522.60110.61%
2004-HK$248.14-61.63%
2003-HK$646.68186.67%
2002-HK$225.58
2001N/A-100%
2000-HK$180.47-63.64%
1999-HK$496.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.25-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.40-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.65-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.26-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.51-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$2.74-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA